Cardiac Coherence Combined With Personal Physical Activity in Patients With Cancer (APACCHE)
Primary Purpose
Physical Activity, Cancer, Hematologic Diseases
Status
Unknown status
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Cardiac Coherence
Adapted Physical Activity
Sponsored by
About this trial
This is an interventional supportive care trial for Physical Activity
Eligibility Criteria
Inclusion Criteria:
- All patients, previously treated and in remission for an Hematologic malignancy, in whom APA is indicated.
- Adult patients aged 18-65 yo
- Followed at South University Hospital of La Réunion Island
- Previously treated for Hematologic Malignancy, and in Remission (complete or partial)
- 6 months or less since last treatment
- Hemoglobin steady ≥ 90g/L
- In whom APA is prescribed
- Ability to give oral informed consent
- French understanding
Exclusion Criteria:
- With contraindication for APA
- Under anti-arhythmic or beta-blocker drugs
- Cardiac insufficiency (Left ventriculi Ejection Fraction less than 40%)
- Participation in another trial
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Active Comparator
Arm Label
Cardiac Coherence
Adapted Physical Activity
Arm Description
Patients participate to Adapted physical activity sessions and to cardiac coherence sessions
Patients only participate to Adapted physical activity sessions
Outcomes
Primary Outcome Measures
Health-related quality of life
Health-related quality is assessed by the Quality of Life Questionnaire dedicated to cancer patients and including 30 items (QLQ-C30) developed by the European Organization for Research and Treatment of Cancer (EORTC). This questionnaire is a multimodal construct, typically including physical, emotional and psychological health issues; evaluated with the QLQ-C30 survey of the European Organization for Research and Treatment of Cancer.
QLQ-C30 items are coded with the same response categories as items 6 to 28, namely "Not at all", "A little", "Quite a bit" and "Very much." Score ranges from 0 to 100, with higher score indicating higher levels of quality of life.
Secondary Outcome Measures
Fatigue improvement
Fatigue improvement is assessed by multidimensional fatigue inventory (MFI-20 survey).
MFI-20 consists of five subscales used to express: general fatigue, physical, reduced activities, reduced motivation, mental fatigue.
Each scale contains four items for which the person had to indicate the extent the items describe their situations in the recent few days on a 5-point Likert scale, ranging from "yes, that is true" to "no, that is not true" Scores on each subscale range from 4 to 20, with higher scores indicating higher levels of fatigue.
Anxiety and depression improvement with Hospital Anxiety and Depression Scale (HADS) survey
Anxiety and depression improvement is assessed by HADS survey. The HADS is a fourteen item scale that generates ordinal data. Seven of the items relate to anxiety and seven relate to depression. Each item on the questionnaire is scored from 0-3: a person can score between 0 and 21 for either anxiety or depression.
Higher scores indicate higher levels of depression or anxiety
Cardiac coherence improvement
Increased percentage of cardiac coherence is measured with SYMBIOLINE software
Full Information
NCT ID
NCT03356171
First Posted
November 23, 2017
Last Updated
December 18, 2017
Sponsor
Centre Hospitalier Universitaire de la Réunion
1. Study Identification
Unique Protocol Identification Number
NCT03356171
Brief Title
Cardiac Coherence Combined With Personal Physical Activity in Patients With Cancer
Acronym
APACCHE
Official Title
Combination of Cardiac Coherence to Physical Activity
Study Type
Interventional
2. Study Status
Record Verification Date
December 2017
Overall Recruitment Status
Unknown status
Study Start Date
January 2018 (Anticipated)
Primary Completion Date
March 2019 (Anticipated)
Study Completion Date
June 2019 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Centre Hospitalier Universitaire de la Réunion
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
APACCHE (Adapted Physical Activity and Cardiac Coherence in HEmatologic patients) study investigates effects of heart rate variability biofeedback training, combined with classical adapted physical activity, on health-related quality of life in patients previously treated for hematologic malignancies. It is a prospective, randomized clinical trial from University Hospital of Reunion Island. The main objective is evaluated with QLQ-C30 survey score differences.
Detailed Description
Hematologic malignancies are aggressive cancers with significant long-term effects on physical and psychological health, due to the disease itself or aggressive treatments. Physical activity, with specific treatments, improves physical and psychological health in solid tumors patients. However, in hematologic malignancies, there is unsatisfactory quality of evidence that physical activity alone improves the various dimensions of quality of life.
Recent studies on heart-brain connections suggest that a high level of coherence in the heart rate variability may induce psychophysiological positive effects. Cardiac coherence is reached when the heart rhythm pattern becomes sine-wave-like at a frequency around 0.1 Hz. This status can be increased by the mean of deep and slow breathing control and/or positive emotions. By using a heart rate variability biofeedback training, previous studies have shown effects on physiological variables such as reduction of blood pressure or increase of vagal heart rate control, and also on psychological variables such as reduction of stress, anxiety, and depression.
The APACCHE protocol investigate if cardiac coherence biofeedback training, associated with an adapted physical activity program, can improve health related quality of life in adult hematologic patients.
70 patients are randomly assigned to receive either ten sessions of cardiac coherence biofeedback (CC-BF) and the adapted physical activity program (APA) or just APA. Both interventions are conducted simultaneously over 12 weeks, with 10 sessions of CC-BF (45mn) weekly and 24 sessions of APA (1h30) bi-weekly.
Data are collected at enrollment(T1), at 6 weeks (T2), at intervention ending at 12 weeks (T3) and after a 24 weeks follow-up (T4).
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Physical Activity, Cancer, Hematologic Diseases
7. Study Design
Primary Purpose
Supportive Care
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
70 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Cardiac Coherence
Arm Type
Experimental
Arm Description
Patients participate to Adapted physical activity sessions and to cardiac coherence sessions
Arm Title
Adapted Physical Activity
Arm Type
Active Comparator
Arm Description
Patients only participate to Adapted physical activity sessions
Intervention Type
Procedure
Intervention Name(s)
Cardiac Coherence
Intervention Description
10 sessions of HRV-BF (45mn) weekly over 12 weeks. HRV-BF is a cognitive behavioural therapy consisting on stress management training based on breathing. We use the SYMBIOLINE PC software to record the heart rate variability biofeedback, with an infrared plethysmograph sensor. The sensor is put on the finger, and the patient's HRV pattern is displayed in real time.
24 APA sessions (1.5h) bi-weekly over 12 weeks. Each session includes aerobic exercises (walk, step) and resistant exercises (muscular reinforcement). This program is built on previous cancer studies to make it effective.
Intervention Type
Procedure
Intervention Name(s)
Adapted Physical Activity
Intervention Description
- 24 APA sessions (1.5h) bi-weekly over 12 weeks. Each session includes aerobic exercises (walk, step) and resistant exercises (muscular reinforcement). This program is built on previous cancer studies to make it effective.
Primary Outcome Measure Information:
Title
Health-related quality of life
Description
Health-related quality is assessed by the Quality of Life Questionnaire dedicated to cancer patients and including 30 items (QLQ-C30) developed by the European Organization for Research and Treatment of Cancer (EORTC). This questionnaire is a multimodal construct, typically including physical, emotional and psychological health issues; evaluated with the QLQ-C30 survey of the European Organization for Research and Treatment of Cancer.
QLQ-C30 items are coded with the same response categories as items 6 to 28, namely "Not at all", "A little", "Quite a bit" and "Very much." Score ranges from 0 to 100, with higher score indicating higher levels of quality of life.
Time Frame
on week 12
Secondary Outcome Measure Information:
Title
Fatigue improvement
Description
Fatigue improvement is assessed by multidimensional fatigue inventory (MFI-20 survey).
MFI-20 consists of five subscales used to express: general fatigue, physical, reduced activities, reduced motivation, mental fatigue.
Each scale contains four items for which the person had to indicate the extent the items describe their situations in the recent few days on a 5-point Likert scale, ranging from "yes, that is true" to "no, that is not true" Scores on each subscale range from 4 to 20, with higher scores indicating higher levels of fatigue.
Time Frame
through study completion: initially (T1), at 6 weeks (T2), 12 weeks (T3) and after at 24 weeks (T4) follow-up
Title
Anxiety and depression improvement with Hospital Anxiety and Depression Scale (HADS) survey
Description
Anxiety and depression improvement is assessed by HADS survey. The HADS is a fourteen item scale that generates ordinal data. Seven of the items relate to anxiety and seven relate to depression. Each item on the questionnaire is scored from 0-3: a person can score between 0 and 21 for either anxiety or depression.
Higher scores indicate higher levels of depression or anxiety
Time Frame
through study completion: initially (T1), at 6 weeks (T2), 12 weeks (T3) and after at 24 weeks (T4) follow-up
Title
Cardiac coherence improvement
Description
Increased percentage of cardiac coherence is measured with SYMBIOLINE software
Time Frame
through study completion: initially (T1), at 6 weeks (T2), 12 weeks (T3) and after at 24 weeks (T4) follow-up
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
All patients, previously treated and in remission for an Hematologic malignancy, in whom APA is indicated.
Adult patients aged 18-65 yo
Followed at South University Hospital of La Réunion Island
Previously treated for Hematologic Malignancy, and in Remission (complete or partial)
6 months or less since last treatment
Hemoglobin steady ≥ 90g/L
In whom APA is prescribed
Ability to give oral informed consent
French understanding
Exclusion Criteria:
With contraindication for APA
Under anti-arhythmic or beta-blocker drugs
Cardiac insufficiency (Left ventriculi Ejection Fraction less than 40%)
Participation in another trial
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Christine JUHEL, PHD
Phone
+262262359949
Email
christine.juhel@chu-reunion.fr
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Quentin CABRERA, MD
Organizational Affiliation
Centre Hpospitalier Universitaire de La REUNION
Official's Role
Principal Investigator
12. IPD Sharing Statement
Plan to Share IPD
No
Citations:
PubMed Identifier
32190333
Citation
Fournie C, Bouscaren N, Dalleau G, Lenclume V, Mohr C, Zunic P, Cabrera Q, Verkindt C. Adapted physical activity and cardiac coherence in hematologic patients (APACCHE): study protocol for a randomized controlled trial. BMC Sports Sci Med Rehabil. 2020 Mar 14;12:18. doi: 10.1186/s13102-020-00170-3. eCollection 2020.
Results Reference
derived
Learn more about this trial
Cardiac Coherence Combined With Personal Physical Activity in Patients With Cancer
We'll reach out to this number within 24 hrs